All In Biotech

Drug Trial Radar · NCT07025811

A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment

A Longitudinal, Open-label, Multi-center Study to Explore the Relationship Between Signs, Symptoms, Molecular and Imaging Biomarkers in Participants With Dry Eye Disease Following Anti-inflammatory Treatment

Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 378 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

378

Actual

Start

Jul 9, 2025

Primary completion

Jul 16, 2026

Study completion Jul 16, 2026

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Jun 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye® or Xiidra®), in participants with dry eye disease (DED) compared to healthy volunteers (control participants).

Conditions

  • Dry Eye Disease

Interventions

  • Vevye®Drug

    Participants will receive Vevye® (0.1% cyclosporine ophthalmic solution) as per the schedule described in the treatment arm.

  • Xiidra®Drug

    Participants will receive Xiidra® (5% lifitegrast ophthalmic solution) as per the schedule described in the treatment arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Corneal Staining as Measured by Sodium FluoresceinTime frame: Up to Week 12

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Eye Research Foundation

    Newport Beach, California

  • Butchertown Clinical Trials

    Louisville, Kentucky

  • Andover Eye Associates

    Andover, Massachusetts

  • Oculus Research

    Garner, North Carolina

  • CORE Inc.

    Shelby, North Carolina

  • Advancing Vision Research, LLC

    Goodlettsville, Tennessee

  • Total Eyecare, P.A.

    Memphis, Tennessee

  • Piedmont Eye Center

    Lynchburg, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.